key: cord-0857171-zp39znki
authors: Falkenhain, Kaja; Locke, Sean R.; Lowe, Dylan A.; Reitsma, Nicholas J.; Lee, Terry; Singer, Joel; Weiss, Ethan J.; Little, Jonathan P.
title: Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial
date: 2021-09-14
journal: Obesity (Silver Spring)
DOI: 10.1002/oby.23242
sha: d88c41c63b95aee17f559e5a79630e80c221fb47
doc_id: 857171
cord_uid: zp39znki

OBJECTIVE: The aim of this study was to determine whether a Mediterranean‐style, ketogenic diet mobile health application (app) with breath acetone biofeedback is superior to a calorie‐restricted, low‐fat diet app in promoting weight loss. METHODS: Participants (n = 155) with overweight/obesity (mean [SD]: age 41 [11] years, BMI = 34 [5] kg/m(2), 71% female) were randomized to one of the interventions delivered entirely via app. Participants received a wireless scale and were instructed to take daily weight measurements. A third‐party laboratory collected blood samples at baseline and 12 weeks. RESULTS: Weight loss at 12 weeks was greater in the ketogenic (−5.6 kg; 95% CI: −6.7 kg to −4.5 kg) compared with the low‐fat group (−2.5 kg; 95% CI: −3.6 kg to −1.4 kg) (between‐group difference: −3.1 kg; 95% CI: −4.6 kg to −1.5 kg; p < 0.001). Weight loss at 24 weeks indicated durability of the effect (between‐group difference: −5.5 kg; 95% CI: −8.3 kg to −2.8 kg; p < 0.001). Secondary/exploratory outcomes of hemoglobin A1c and liver enzymes were improved to a greater extent in the ketogenic diet group (p < 0.01). CONCLUSIONS: Among adults with overweight/obesity, a ketogenic diet app with breath acetone biofeedback was superior to a calorie‐restricted diet app at promoting weight loss in a real‐world setting.

comprehensive, app-based weight loss program incorporating a Mediterranean-style ketogenic diet paired with a breath acetone biofeedback device. The app combines resources (e.g., recipes, searchable database, meal plans) with self-monitoring in the form of an accompanying breath acetone sensor to help individuals learn about how different foods impact their level of ketosis. The program emphasizes a Mediterranean-style ketogenic diet, encouraging intake of low-carbohydrate foods that are high in monounsaturated and omega-3 polyunsaturated fatty acids without concomitant increases in the intake of foods rich in saturated fatty acids. This was designed in response to concerns that traditional ketogenic diets high in saturated fats might have adverse effects on cardiovascular risk markers (6) .

The purpose of this pragmatic randomized trial was to test the efficacy of the Keyto diet app and breath acetone biofeedback device compared with the WW diet app (WW, Inc., New York, New York). The WW app was chosen as an evidence-based weight loss intervention effective at reducing weight and cardiovascular risk (7, 8) , such that the ketogenic diet app and biofeedback device could be tested against a well-known and well-studied active comparator. We hypothesized greater weight loss for individuals randomized to the ketogenic diet app paired with a breath acetone biofeedback device compared with the calorie-restricted, low-fat diet app.

This study examines the prespecified primary and secondary outcomes at 12 weeks from baseline using a two-group pragmatic randomized trial. Using a virtual hands-off design, participants were mailed study materials and they interacted with study staff via email, text messages, or phone calls only. The study was conducted with approval from the University of British Columbia's clinical research ethics board, and all participants provided written informed consent digitally prior to data collection. The clinical trial was registered on ClinicalTrials.gov (NCT04165707) and the protocol published (DERR1-10.2196/19053) (9) .

A total of 155 participants with overweight/obesity (BMI 27 to 43 kg/m 2 ) from the state of California were recruited between December 1, 2019, and August 11, 2020 , and randomized to one of the interventions. Key exclusion criteria were pregnancy, current smoker, diabetes diagnosis, history of heart attack, bariatric surgery, eating disorder, losing or gaining more than 5% body weight in past 6 months, and currently following a low-carbohydrate or ketogenic diet (9) . The original published protocol aimed to recruit 144 participants per the a priori sample size calculation in order to detect a clinically meaningful 5% difference in weight loss with 80% power and α = 0.5 with two groups and two time points (baseline and primary outcome at 12 weeks), assuming a mean body mass of 100 kg with a standard deviation of 15 kg and a correlation among repeated measures of r = 0.75 (9) . To account for an expected increase in dropout rate due to the challenges of the COVID-19 pandemic, the trial steering committee decided to increase enrollment to 155 participants on July 28, 2020. Randomization schedule was maintained by a third-party, password-protected website using variable permuted block sizes and stratified by sex (male, female) and age (18 to 40, 41 to 64 years).

What is already known?

► Ketogenic diets have been demonstrated to be effective for weight loss; however, concerns remain regarding potential adverse effects of a ketogenic diet high in (saturated) fat on cardiovascular risk markers.

► Mobile technology now makes delivery of dietary interventions easily accessible and scalable; and breath acetone has been suggested to be viable biofeedback for monitoring fat loss, specifically during a lowcarbohydrate, ketogenic diet.

► A self-managed, Mediterranean-based ketogenic diet intervention delivered entirely remotely via an app and paired with a breath acetone biofeedback device was superior in achieving weight loss at 12 and 24 weeks compared with a low-fat, calorie-restricted comparator arm.

► The ketogenic diet intervention improved hemoglobin A1c and liver enzymes to a greater extent than the lowfat, calorie-restricted diet intervention, with no detrimental outcomes in other risk factors, including lipids and lipoproteins.

How might these results change the direction of research or the focus of clinical practice? ► Our findings highlight the opportunity to successfully implement a ketogenic diet remotely.

► App-based interventions may help aid implementation and scalability of ketogenic diets to promote weight loss and improve metabolic health.

At the start of the study, participants received a phone call to provide assistance with setting up of study devices and a brief introduction to their respective diet app and eating plan. Following that, both interventions were delivered entirely via a mobile app with no in-person meetings or dietary counseling outside of the app's framework. The Mediterranean-style ketogenic diet app, paired with a breath acetone biofeedback device, uses a traffic light system to recommend consumption of foods (ad libitum, cautiously, avoid) according to the amount of net carbohydrates based on nutritional information gathered from the United States Department of Agriculture food database. The app emphasizes avoidance of refined carbohydrates, and priority is placed on fats from plant-(e.g., olive oil, avocado, nuts) and fish-based (e.g., salmon) sources that fit the Mediterranean guidelines (10) and that are indicated with a "Heart First" badge.

Participants in the trial were encouraged to prioritize foods that fall in this category. The app is paired with a biofeedback device that measures breath acetone levels as a proxy for level of nutritional ketosis. The breath acetone device is roughly the size of a pen, consisting of a gas sensor using a semiconducting metal oxide core selective for acetone, with each sensor individually calibrated with acetone standard gas during the production process (11) . Participants were instructed to use the device three times daily, with their level of ketosis provided within the paired app on a scale of 0 (lowest) to 6+ (highest). In case of a lower score (0 to 3), participants were instructed to further restrict carbohydrate intake, whereas in case of a higher score (4 or higher), participants were encouraged to continue with their current dietary habits. The calorie-restricted, low-fat diet app intervention uses a points-based tracking system and requires participants to record their food and beverage intake in the app, which assigns a points value to each item. The points value is based on caloric content of each food item, with protein content lowering and saturated fat and sugar increasing the value. Based on baseline anthropometrics, a daily points value is calculated, which participants are instructed not to exceed. Furthermore, the app contains so-called zero-point low-calorie foods that can be consumed ad libitum and that do not count toward the daily points allotment (12) . Both apps provided similar ancillary resources, including recipes, a food search option, and a social support function, as detailed previously (9) .

Participants received an iHealth Lite Bluetooth scale (Model Lina H2; iHealth, Mountain View, California) via mail and they were instructed to measure their weight daily. Weight measurements were automatically uploaded to the iHealth cloud where they could be accessed by the researchers. Weight loss at 12 weeks was the preregistered primary outcome.

At baseline and at 12 weeks, a fasted blood sample was obtained by a third-party laboratory (Quest Diagnostics, Secaucus, New Jersey) for measuring metabolic and cardiovascular risk markers.

Participants completed weekly and monthly survey measures as manipulation checks of adherence and intervention fidelity.

Surveys were sent via email and they included the Automated Self-Administered 24-Hour Dietary Recall (13), the Pittsburgh Sleep Quality Index (14) , and questionnaires about food attitude, diet adherence, physical activity (15) , and cravings, mood, and energy. We also explored the durability of the effect on weight loss by assessing the change in body mass at 24 weeks using available data from the Bluetooth-and cloud-connected weigh scales.

The primary objective of this trial was to test the superiority of the ketogenic diet app with breath acetone biofeedback compared with the calorie-restricted, low-fat diet app, for promoting weight loss after 12 weeks. Blinded data were analyzed on an intention-to-treat basis. We used constrained baseline longitudinal analysis via a linear Effect estimates for within-group changes over time are also reported.

Statistical significance was established at an α level of 0.05. Baseline weight was the weight recorded on the first day of the trial or, if no weight was logged on that day, the closest weight measurement to 8 AM on the start date of the trial. Postintervention weight was calculated as the average (mean) weight of the final (i.e., 12th) week of the intervention phase. Sensitivity analysis on the primary outcome was performed in a similar manner using a linear mixed model with all available daily weight measures (as opposed to using only baseline and postintervention weight for the primary analysis). Secondary end points were analyzed similarly. Bonferroni-adjusted critical α was used for secondary outcomes to account for multiple comparisons.

No α adjustments were applied to exploratory outcomes. To explore the impacts of the different diets independent of weight loss, we reran the linear mixed model on secondary and exploratory outcomes that were statistically significant with baseline weight and change in body mass included as additional fixed effects. The statistical analysis plan is presented in the online Supporting Information.

Of the 155 randomized participants, 116 (75%) completed the 12week intervention; 60 (78%) and 56 (72%) participants were retained in the Mediterranean-style ketogenic diet app paired with breath acetone biofeedback group and in the calorie-restricted, low-fat diet app group, respectively ( Figure 1 ). Basic baseline characteristics are shown in Table 1 . Socioeconomic participant characteristics are presented in Supporting Information Table S1.

There was a decrease in body mass in the ketogenic diet app with biofeedback group (−5.6 kg; 95% CI: −6.7 kg to −4.5 kg) and in the calorie-restricted, low-fat diet app group (−2.5 kg; 95% CI: Figure S1 ).

There was no significant difference in self-reported energy intake between intervention groups across the 12 weeks (16 kcal; 95% CI:

−68 kcal to 101 kcal; P = 0.71). The ketogenic diet app with biofeedback group reported consuming significantly less carbohydrates and significantly more total fat, saturated fat, and monounsaturated fat compared with the calorie-restricted, low-fat diet app group.

There was no significant difference in self-reported intake of polyunsaturated fat between the intervention groups. Full analyses of self-reported dietary intake data are presented in Supporting Information Table S2 .

There was a significantly greater decrease in hemoglobin A1c (HbA1c) at 12 weeks in the ketogenic diet app with biofeedback Table S3 . There were no other differences between groups in assessed blood markers of cardiometabolic risk at 12 weeks (Table 2) . 

The Mediterranean-style ketogenic diet app paired with a breath acetone biofeedback device was found to result in superior weight loss than the calorie-restricted, low-fat diet app, with secondary The mechanisms leading to greater weight loss in the ketogenic diet app group despite no significant difference in self-reported energy intake between groups are unclear. Previous research suggests that energy intake may be overreported on low-carbohydrate diets during the initial months of the dietary intervention (18) or that diets lower in carbohydrates may increase total energy expenditure (19) . However, estimation of energy intake in our study There is mixed evidence regarding the relative effectiveness of low-carbohydrate diets compared with those restricted in fat and/ TA B L E 2 Effect estimates for 12-week changes in body mass (primary outcome) and blood markers (secondary/exploratory outcomes) All data are presented as (within-group or between-group) effect estimates (95% CI). Effect estimates are based on intention-to-treat analyses and included all participants that had a baseline or a follow-up value (n = 146 for body mass and n = 151 for blood analyses). Bonferroni-adjusted critical α of 0.003 is used for secondary outcomes. reported that an isoenergetic substitution of saturated and trans monounsaturated fatty acids for carbohydrates raises, whereas an exchange of carbohydrates with cis poly-or monounsaturated fatty acids lowers LDL cholesterol (26) . Our data extend these previous findings by providing evidence that an app promoting a Mediterranean-style ketogenic diet emphasizing monounsaturated and polyunsaturated fatty acids over saturated fatty acids may be a viable option to provide metabolic and weight loss benefits without potential negative effects on blood lipids and associated cardiovascular risk.

Although a strength of the study includes its real-world, handsoff intervention, the weight measurements were self-administered on an at-home wireless scale, which may not have been as accurate as if they were obtained through clinician-assessment. Similarly, the dietary intake data were limited by relying on self-report at discrete time points, which can introduce bias (27) and limit accuracy (18) .

It is likely that not every participant in the ketogenic diet with biofeedback group achieved and maintained nutritional ketosis. As such, weight loss findings should be interpreted as being the result of an app and biofeedback-based app that promotes the ketogenic diet under free-living conditions rather than the effects of a strict ketogenic diet per se. Despite this inevitable consequence of the pragmatic study design, robust weight loss differences were observed. Furthermore, the primary end-phase of this study was at 12 weeks. Exploratory analysis of change in body mass at 24 weeks suggests the durability of the effect, but findings should not be generalized beyond that point until planned longer-term secondary analyses can be performed. Similarly, findings should not be generalized beyond the current study population, which was composed of generally healthy adults with overweight and obesity.

Although our virtual trial was designed prior to the COVID-19

outbreak, most of this study occurred during the pandemic. To account for an expected increase in dropout, we decided to increase target enrollment as specified in the statistical analysis plan (see online Supporting Information). Participants generally reported minor negative impacts of the pandemic on their ability to stick with their program (Supporting Information Table S4 ) and were mostly able to complete the study despite any challenges posed.

In this 12-week randomized clinical trial, dietary advice to follow an app-based Mediterranean-style ketogenic diet resulted in greater weight loss compared with the advice to follow an appbased, standard calorie-restricted, low-fat diet. We found select biomarkers of glycemic control and hepatic function to be improved in the ketogenic diet group; however, there were no significant differences between groups for the majority of cardiometabolic health markers assessed. This suggests that an appbased ketogenic diet with breath acetone biofeedback is superior to a calorie-restricted, low-fat diet app intervention to achieve weight loss and improve metabolic health in a real-world setting.

Future studies should aim to evaluate the long-term effectiveness of such an intervention and its potential role in treatment of obesity-related diseases.O

Data collected for this study, including individual deidentified participant data and a data dictionary defining each field in the set, will be made available to others with an academic affiliation upon reasonable request from the corresponding author. The published study protocol is available (9) .

JPL is chief scientific officer for the Institute for Personalized Therapeutic Nutrition, a not-for-profit organization promoting a food-first approach to treating and preventing chronic disease. JPL holds shares in Metabolic Insights Inc., a for-profit company developing a saliva insulin monitor. EJW is an equity holder at Keyto and Virta Health. DAL is employed as a consultant for Keyto. All other authors have no conflicts to declare.

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets

Can mobile technology improve weight loss in overweight adults? A systematic review

Mobile health applications in weight management: a systematic literature review

Self-monitoring in weight loss: a systematic review of the literature

Measuring breath acetone for monitoring fat loss: review

Review of current evidence and clinical recommendations on the effects of lowcarbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: a scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force

Efficacy of commercial weight-loss programs

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction

Comparing the Keyto app and device with Weight Watchers' WW app for weight loss: protocol for a randomized trial

Primary prevention of cardiovascular disease with a Mediterranean diet

The science behind Keyto, part one -how the Keyto breath sensor works

SmartPoints: Starter Guide

The Automated Self-Administered 24-Hour Dietary Recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute

The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research

A simple method to assess exercise behavior in the community

Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials

A randomized trial of a lowcarbohydrate diet for obesity

Objective versus selfreported energy intake changes during low-carbohydrate and lowfat diets

Do lower-carbohydrate diets increase total energy expenditure? An updated and reanalyzed meta-analysis of 29 controlled-feeding studies

Low-carbohydrate diets for overweight and obesity: a systematic review of the systematic reviews

Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC "diet trials

A low-carbohydrate as compared with a low-fat diet in severe obesity

Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial

The effects of lowcarbohydrate diets on cardiovascular risk factors: a metaanalysis

Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets

Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials

Comparison of self-reported dietary intakes from the Automated Self-Administered 24-h recall, 4-d food records, and food-frequency questionnaires against recovery biomarkers

Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile